文献速递瓣膜外科先天性心脏病外科

儿童机械二尖瓣置换术的结局

Outcomes of Mechanical Mitral Valve Replacement in Children.
PubMed 文献 · Ann Thorac Surg · 2018-09-26

基于美国多机构儿科心脏护理联盟注册数据,纳入441例2岁以下首次行机械二尖瓣置换的先天性心脏病患者,早期死亡率11.1%,2岁以下手术及合并其他机械瓣置换增加早期死亡风险,存活者20年无移植生存率76%。

要点

  • 2岁以下首次机械二尖瓣置换早期死亡风险增高(OR 7.8)。
  • 合并其他机械瓣置换增加早期死亡风险(OR 8.5)。
  • 存活超过90天者20年无移植生存率76%。

核心结论

  • 机械二尖瓣置换是不可修复二尖瓣病变患儿的可行策略。
  • 首次机械二尖瓣置换时年龄小于2岁与显著早期死亡风险和较差长期生存相关。

研究设计与样本

  • 回顾性队列研究,查询美国多机构儿科心脏护理联盟注册数据库,纳入441例因双心室先天性心脏病首次行机械二尖瓣置换、年龄小于21岁的患者。
  • 生存和移植状态通过儿科心脏护理联盟及与国家死亡指数和器官获取与移植网络链接获取至2014年。

主要发现

  • 中位年龄4.3岁(四分位距1.3至10.1岁),最常见病因为房室通道(44.3%)。
  • 早期死亡率(机械二尖瓣置换后90天内死亡)为11.1%。
  • 年龄小于2岁行机械二尖瓣置换的早期死亡风险增高(OR 7.8;95%CI 1.1至56.6)。
  • 合并其他机械瓣置换的早期死亡风险增高(OR 8.5;95%CI 2.0至35.6)。
  • 存活超过90天者20年无移植生存率为76%(中位随访16.6年;四分位距11.9至21.3年)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral valve anomalies in children are rare but frequently severe, recalcitrant, and not often amenable to primary repair, necessitating mechanical mitral valve replacement (M-MVR). This study examined outcomes of a cohort undergoing a first M-MVR at age younger than 21 years. METHODS: We queried the Pediatric Cardiac Care Consortium, a multi-institutional United States-based cardiac intervention registry, for patients undergoing first M-MVR for 2-ventricle congenital heart disease. Survival and transplant status through 2014 were obtained from Pediatric Cardiac Care Consortium and linkage with the National Death Index and the Organ Procurement and Transplantation Network. RESULTS: We identified 441 patients (median age, 4.3 years; interquartile range, 1.3 to 10.1 years) meeting study criteria. The commonest disease necessitating M-MVR was atrioventricular canal (44.3%). Early mortality (death <90 days after M-MVR) was 11.1%; there was increased risk of early death if age at M-MVR was younger than 2 years (odds ratio, 7.8; 95% confidence interval [CI], 1.1 to 56.6) and with concurrent other mechanical valve placement (odds ratio, 8.5; 95% CI, 2.0 to 35.6). In those surviving more than 90 days after M-MVR, transplant-free survival was 76% at 20 years of follow-up (median follow-up, 16.6 years; interquartile range, 11.9 to 21.3 years). Adjusted analysis in those who survived more than 90 days showed elevated risk of death/transplant for boys (hazard ratio, 1.5; 95% CI, 1.0 to 2.3), age at M-MVR younger than 2 years (10-year survival: hazard ratio, 4.3; 95% CI, 1.2 to 15.1), and nonbileaflet prosthesis placement (hazard ratio, 2.4; 95% CI, 1.3 to 4.3). CONCLUSIONS: M-MVR is a viable strategy in children with unrepairable mitral valve disease. Age younger than 2 years at the first M-MVR is associated with significant early risk of death and poorer long-term survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Ibezim C, Sarvestani AL, Knight JH, et al. Outcomes of Mechanical Mitral Valve Replacement in Children. Ann Thorac Surg. 2018. PMID: 30267694. doi:10.1016/j.athoracsur.2018.07.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。